Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 216(suppl_1): S130-S136, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28838156

ABSTRACT

Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, "new vaccine introductions" [NVIs]) can help countries implement robust project management systems, front-load critical preparatory activities, and ensure continuous communication around vaccine supply and financing. In addition, implementing postlaunch assessments to take rapid corrective action accelerates the uptake of the new vaccines. NVIs can provide an opportunity to strengthen routine immunization, through strengthening program management systems or by reinforcing local immunization managers' abilities, among others. This article highlights key lessons learned during the introduction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful. The article concludes by considering how the Immunization Systems Management Group of the Global Polio Eradication Initiative has been useful to the NVI process and how such global structures could be further enhanced.


Subject(s)
Disease Eradication , Immunization Programs , Poliomyelitis/prevention & control , Poliovirus Vaccine, Inactivated , Africa South of the Sahara , Disease Eradication/methods , Disease Eradication/organization & administration , Humans , Immunization Programs/methods , Immunization Programs/organization & administration , Poliovirus Vaccine, Inactivated/administration & dosage , Poliovirus Vaccine, Inactivated/supply & distribution
2.
Vaccine ; 35(17): 2107-2109, 2017 04 19.
Article in English | MEDLINE | ID: mdl-28364916

ABSTRACT

In many countries, one of the common factors limiting full and equitable access to effective immunization is the existence of gaps in cold chain and logistics (CCL) systems. This article focuses on the critical contribution that better management of CCL performance can make in addressing these barriers, as well as some essential practices needed to achieve and sustain these gains. These include (i) an emphasis on continuous improvement in CCL performance indicators, (ii) strong coordination and accountability across multiple stakeholders, and (iii) making the most of limited financial resources. This article is informed by the Clinton Health Access Initiative's (CHAI's) experience working with National Immunization Programs (NIPs) and immunization partners to improve the effectiveness and efficiency of CCL systems (including CCE deployment and maintenance, temperature monitoring and control, stock management and distribution) across ten Gavi-supported "focus" countries.


Subject(s)
Immunization Programs/organization & administration , Organization and Administration , Refrigeration/methods , Vaccines/supply & distribution , Developing Countries , Humans , Refrigeration/trends
3.
Vaccine ; 35(17): 2217-2223, 2017 04 19.
Article in English | MEDLINE | ID: mdl-27670076

ABSTRACT

While a number of new vaccines have been rolled out across the developing world (with more vaccines in the pipeline), cold chain systems are struggling to efficiently support national immunization programs in ensuring the availability of safe and potent vaccines. This article reflects on the Clinton Health Access Initiative, Inc. (CHAI) experience working since 2010 with national immunization programs and partners to improve vaccines cold chains in 10 countries-Ethiopia, Nigeria, Kenya, Malawi, Tanzania, Uganda, Cameroon, Mozambique, Lesotho and India - to identify the root causes and solutions for three common issues limiting cold chain performance. Key recommendations include: Collectively, the solutions detailed in this article chart a path to substantially improving the performance of the cold chain. Combined with an enabling global and in-country environment, it is possible to eliminate cold chain issues as a substantial barrier to effective and full immunization coverage over the next few years.


Subject(s)
Drug Storage/methods , Immunization Programs , Refrigeration/instrumentation , Refrigeration/methods , Vaccines/supply & distribution , Africa , Developing Countries , Humans , India
SELECTION OF CITATIONS
SEARCH DETAIL
...